Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells

Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: نصرت اله ضرغامی , یونس پیله ور سلطان احمدی , مهدی داداش پور , وحید شفیعی ایران نژاد

کلمات کلیدی: Metformin; curcumin; PLGA/ PEG; synergistic effect; breast cancer

نشریه: 39930 , 0 , 0 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله نصرت اله ضرغامی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده پزشکی
کد مقاله 61752
عنوان فارسی مقاله Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
عنوان لاتین مقاله Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق) Artificial Cells, Nanomedicine, and Biotechnology
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت http://www.tandfonline.com/doi/abs/10.1080/21691401.2017.1347879?journalCode=ianb20

خلاصه مقاله
hide/show

The study was aimed at investigating the synergistic inhibitory effect of unique combinational regimen of nanocapsulated Metformin (Met) and Curcumin (Cur) against T47D breast cancer cells. For this purpose, Met and Cur were co-encapsulated in PEGylated PLGA nanoparticles (NPs) and evaluated for their therapeutic efficacy. The morphology and dynamic light scattering (DLS) analyses were carried out to optimize the nanoformulations. Drug release study was performed using dialysis method and then the cytotoxic and inhibitory effect of individual and combined drugs on expression level of hTERT in T47D breast cell line were evaluated using MTT assay and qPCR, respectively. The results showed that free drugs and formulations exhibited a dose-dependent cytotoxicity against T47D cells and especially, Met–Cur–PLGA/PEG NPs had more synergistic antiproliferative effect and significantly arrested the growth of cancer cells than the other groups (p < .05). Real-time PCR results revealed that Cur, Met and combination of Met–Cur in free and encapsulated forms inhibited hTERT gene expression. It was found that Met–Cur–PLGA/PEG NPs in relative to free combination could further decline hTERT expression in all concentration (p < .05). Taken together, our study demonstrated that Met–Cur–PLGA/PEG NPs based combinational therapy holds promising potential towards the treatment of breast cancer.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
نصرت اله ضرغامیهشتم
یونس پیله ور سلطان احمدیدوم
مهدی داداش پورسوم
وحید شفیعی ایران نژادهفتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Nano-encapsulated metformin-curcumin in PLGA PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.pdf1396/08/171323962دانلود